Evidence map›Paper›PMID 31690324›Full record

ArticleAnnals of clinical microbiology and antimicrobials2019

Exploring the phenotype and genotype of multi-drug resistant Klebsiella pneumoniae harbouring bla

Sandip Patil, Xiaowen Chen, Feiqiu Wen

Abstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Molecular epidemiological analysis of blaAnnals of clinical microbiology and antimicrobials · 2024
    Article
  2. Article
  3. Phenotypic and Molecular Characterization of Hypervirulent and Multidrug-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  4. Pandemic one health clones ofFrontiers in cellular and infection microbiology · 2023
    Article
  5. Article
  6. Article
  7. Genetic Characterization of Colistin-ResistantInfection and drug resistance · 2022
    Article
  8. Genome-Based Analysis ofPathogens (Basel, Switzerland) · 2021
    Article
  9. Article
  10. FecalFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sandip PatilDepartment of Haematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, District Futian, Shenzhen, 518038, Guangdong Province, China.
Xiaowen ChenPaediatric Research Institute, Shenzhen Children's Hospital, 7019 Yitian Road, District Futian, Shenzhen, 518038, Guangdong Province, China.
Feiqiu WenDepartment of Haematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, District Futian, Shenzhen, 518038, Guangdong Province, China. fwen62@163.com.

Funding

Sanming Project of Medicine in Shenzhen SZSM201512033Sciences and Technology Project from science technology and innovation committee of Shenzhen municipality JCYJ20170817170110940
6 · The paper itself

Abstract

backgroundEmergence and spread of β-lactamase resistant Klebsiella pneumoniae have posed a serious threat, especially in paediatric patients globally. The present study focuses on explore drug resistance profile and molecular characterization of carbapenemase and extended-spectrum β-lactamase producing K. pneumoniae isolated from paediatric patients in Shenzhen, China.

methodsPresent study, a total of 31 isolates of multi-drug resistant K. pneumoniae were collected from Shenzhen Children's Hospital, China during Jan 2014 to December 2015. ESBLs production was confirmed by using the combination disc diffusion method followed by antimicrobial susceptibility. In addition, β-lactamase encoding genes were determined by PCR assay and sequencing. The genotypic diversity and phylogenetic relationship were determined by multi-locus sequence typing (MLST) method and pulsed-field gel electrophoresis (PFGE).

resultsWe examined 31, unique K. pneumoniae isolates collected from 2014 and 2015 in Shenzhen Children's Hospital, China. All the 31 isolates 100% were resistant to ceftazidime, ertapenem, ampicillin, cefazolin and ampicillin-sulbactam followed by ceftriaxone 94% (n = 29), aztreonam 89% (n = 26), cefepime 84% (n = 26), nitrofurantoin 75% (n = 24), piperacillin 52% (n = 16), and levofloxacin 49% (n = 15). Of the 31 β-lactamase gene coding isolates, bla

conclusionOur study reports the occurrence and spread of extended β-lactamase K. pneumoniae ST20 and ST2407 for the first time, in Shenzhen, particularly in paediatric patients. To prevent and control the infection by limiting the spread of infection-causing organisms it is very crucial to detect the presence of resistant genes at an early stage.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesChildChild HealthChild, PreschoolChinaDrug Resistance, Multiple, BacterialFemaleGenes, BacterialHumansInfantKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial Agentsbeta-LactamasesAntimicrobial susceptibilityESBLsKlebsiella pneumoniaeMolecular characterization

Identifiers

PMID31690324
PMCPMC6829983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.